Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
★★★★★
☆☆☆☆☆
USD 180 /hr
Hire Dr. Ryan R.
United States
USD 180 /hr

Biostatistician & Associate Professor | Statistical review, survival analysis, clinical trials, R & Python

Profile Summary
Subject Matter Expertise
Services
Writing Clinical Trial Documentation, Medical Writing
Work Experience

Karolinska Institutet

- Present

Karolinska University Hospital

- Present

CEO, Founder

The Responder Lab

August 2022 - Present

Senior Statistical Analyst

American Heart Association

May 2021 - December 2021

Co-Founder and Managing Partner

DataVerge

January 2017 - April 2021

Researcher, Department of Mathematics

KTH Royal Institute of Technology

August 2012 - April 2021

Education

PhD in Medical Science (Laboratory Medicine)

Karolinska Institutet

June 2006 - January 2011

International MBA

IE Business School

August 2002 - December 2003

Master of Science (Material Science and Engineering)

Kungliga Tekniska Hogskolan

January 1999 - June 2000

Bachelor of Science with Honors (Engineering Science and Mechanics)

Pennsylvania State University

September 1992 - May 1996

Certifications
  • Certification details not provided.
Publications
JOURNAL ARTICLE
Ryan Ramanujam, Graysen Steele Boles, Jan Hillert, Helga Westerlind, Tomas Olsson, Ingrid Kockum, Ali Manouchehrinia (2023). The familial risk and heritability of multiple sclerosis and its onset phenotypes: A case–control study . Multiple Sclerosis Journal.
Ryan Ramanujam, Lars Forsberg, Tim Spelman, Pernilla Klyve, Ali Manouchehrinia, Elena Mouresan, Jiri Drahota, Dana Horakova, Hanna Joensen, Luigi Pontieri, et al. (2023). Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers . Multiple Sclerosis Journal - Experimental, Translational and Clinical.
Ryan Ramanujam, Ali Manouchehrinia, Elaine Kingwell, Feng Zhu, Helen Tremlett, Jan Hillert (2021). A multiple sclerosis disease progression measure based on cumulative disability . Multiple Sclerosis Journal.
Ryan Ramanujam, Henri Riihimäki, Wojciech Chachólski, Jakob Theorell, Jan Hillert(2020). A topological data analysis based classification method for multiple measurements . BMC Bioinformatics. 21. (1). Springer Science and Business Media {LLC}
Ryan Ramanujam, Loes Crielaard, Andrius Kavaliunas, Tomas Olsson, Jan Hillert, Pernilla Stridh, Ingrid Kockum, Ali Manouchehrinia(2019). Factors associated with and long-term outcome of benign multiple sclerosis: a nationwide cohort study . Journal of Neurology, Neurosurgery & Psychiatry. 90. (7). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 761--767. {BMJ}
Manouchehrinia, A, Westerlind, H, Kingwell, E, Zhu, F, Carruthers, R, Ramanujam, R, Ban, M, Glaser, A, Sawcer, S, Tremlett, H, et al. (2017). Age Related Multiple Sclerosis Severity Score: Disability ranked by age . Mult. Scler.
Link, J, Ramanujam, R, Auer, M, Ryner, M, Hässler, S, Bachelet, D, Mbogning, C, Warnke, C, Buck, D, Hyldgaard Jensen, PE, et al. (2017). Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results . PLoS ONE.
Kavaliunas, A, Manouchehrinia, A, Stawiarz, L, Ramanujam, R, Agholme, J, Hedström, AK, Beiki, O, Glaser, A, Hillert, J (2016). Importance of early treatment initiation in the clinical course of multiple sclerosis . Mult. Scler.
Bachelet, D, Hässler, S, Mbogning, C, Link, J, Ryner, M, Ramanujam, R, Auer, M, Hyldgaard Jensen, PE, Koch-Henriksen, N, Warnke, C, et al. (2016). Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis . PLoS ONE.
Ramanujam, R, Hedström, AK, Manouchehrinia, A, Alfredsson, L, Olsson, T, Bottai, M, Hillert, J (2015). Effect of Smoking Cessation on Multiple Sclerosis Prognosis . JAMA Neurol.
Westerlind, H, Imrell, K, Ramanujam, R, Myhr, KM, Celius, EG, Harbo, HF, Oturai, AB, Hamsten, A, Alfredsson, L, Olsson, T, et al. (2015). Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort . Eur. J. Hum. Genet.
Westerlind, H., Ramanujam, R., Uvehag, D., Kuja-Halkola, R., Boman, M., Bottai, M., Lichtenstein, P., Hillert, J.(2014). Modest familial risks for multiple sclerosis: A registry-based study of the population of Sweden . Brain. 137. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 770-778.
Westerlind, H, Ramanujam, R, Uvehag, D, Kuja-Halkola, R, Boman, M, Bottai, M, Lichtenstein, P, Hillert, J (2014). Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden . Brain.
Engdahl, E., Gustafsson, R., Ramanujam, R., Sundqvist, E., Olsson, T., Hillert, J., Alfredsson, L., Kockum, I., Fogdell-Hahn, A.(2014). HLA-A*02, gender and tobacco smoking, but not multiple sclerosis, affects the IgG antibody response against human herpesvirus 6 . Human Immunology. 75. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 524-530.
Engdahl, E, Gustafsson, R, Ramanujam, R, Sundqvist, E, Olsson, T, Hillert, J, Alfredsson, L, Kockum, I, Fogdell-Hahn, A (2014). HLA-A(∗)02, gender and tobacco smoking, but not multiple sclerosis, affects the IgG antibody response against human herpesvirus 6 . Hum. Immunol.
Westerlind, H., Imrell, K., Ramanujam, R., Myhr, K.-M., Celius, E.G., Harbo, H.F., Oturai, A.B., Hamsten, A., Alfredsson, L., Olsson, T., et al.(2014). Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort . European Journal of Human Genetics.
Westerlind, H., Kuja-Halkola, R., Ramanujam, R., Hillert, J.(2014). Reply: Shared environmental effects on multiple sclerosis susceptibility: Conflicting evidence from twin studies . Brain. 137. (7).
Warnke, C, Dehmel, T, Ramanujam, R, Holmen, C, Nordin, N, Wolfram, K, Leussink, VI, Hartung, HP, Olsson, T, Kieseier, BC (2014). Initial lymphocyte count and low BMI may affect fingolimod-induced lymphopenia . Neurology.
Warnke, C., Ramanujam, R., Plavina, T., Bergström, T., Goelz, S., Subramanyam, M., Kockum, I., Rahbar, A., Kieseier, B.C., Holmén, C., et al.(2013). Changes to anti-JCV antibody levels in a Swedish national MS cohort . Journal of Neurology, Neurosurgery and Psychiatry. 84. (11). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1199-1205.
Warnke, C, Ramanujam, R, Plavina, T, Bergström, T, Goelz, S, Subramanyam, M, Kockum, I, Rahbar, A, Kieseier, BC, Holmén, C, et al. (2013). Changes to anti-JCV antibody levels in a Swedish national MS cohort . J. Neurol. Neurosurg. Psychiatr.
Ramanujam, R., Ramanujam, S., Hillert, J.(2013). Considerations for Subgroups and Phenocopies in Complex Disease Genetics . PLoS ONE. 8. (8).
Ramanujam, R, Ramanujam, S, Hillert, J (2013). Considerations for subgroups and phenocopies in complex disease genetics . PLoS ONE.
Jungedal, R., Lundkvist, M., Engdahl, E., Ramanujam, R., Westerlind, H., Sominanda, A., Hillert, J., Fogdell-Hahn, A.(2012). Prevalence of anti-drug antibodies against interferon beta has decreased since routine analysis of neutralizing antibodies became clinical practice . Multiple Sclerosis. 18. (12). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1775-1781.
Jungedal, R, Lundkvist, M, Engdahl, E, Ramanujam, R, Westerlind, H, Sominanda, A, Hillert, J, Fogdell-Hahn, A (2012). Prevalence of anti-drug antibodies against interferon beta has decreased since routine analysis of neutralizing antibodies became clinical practice . Mult. Scler.
Ramanujam, R., Pirskanen, R., Ramanujam, S., Hammarström, L.(2011). Utilizing twins concordance rates to infer the predisposition to myasthenia gravis . Twin Research and Human Genetics. 14. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 129-136.
Ramanujam, R, Pirskanen, R, Ramanujam, S, Hammarstrom, L (2011). Utilizing Twins Concordance Rates to Infer the Predisposition to Myasthenia Gravis . Twin Res. Hum. Genet.
Ramanujam, R., Piehl, F., Pirskanen, R., Gregersen, P.K., Hammarström, L.(2011). Concomitant autoimmunity in myasthenia gravis - Lack of association with IgA deficiency . Journal of Neuroimmunology. 236. (1-2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 118-122.
Ramanujam, R, Piehl, F, Pirskanen, R, Gregersen, PK, Hammarstrom, L (2011). Concomitant autoimmunity in myasthenia gravis - Lack of association with IgA deficiency . J. Neuroimmunol.
Mohammadi, J., Ramanujam, R., Jarefors, S., Rezaei, N., Aghamohammadi, A., Gregersen, P.K., Hammarström, L.(2010). IgA deficiency and the MHC: Assessment of relative risk and microheterogeneity within the HLA A1 B8, DR3 (8.1) Haplotype . Journal of Clinical Immunology. 30. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 138-143.
Mohammadi, J, Ramanujam, R, Jarefors, S, Rezaei, N, Aghamohammadi, A, Gregersen, PK, Hammarstrom, L (2010). IgA Deficiency and the MHC: Assessment of Relative Risk and Microheterogeneity Within the HLA A1 B8, DR3 (8.1) Haplotype . J. Clin. Immunol.
Ramanujam, R, Zhao, YF, Pirskanen, R, Hammarstrom, L (2010). Lack of association of the CIITA-168A -> G promoter SNP with myasthenia gravis and its role in autoimmunity . BMC Med. Genet.
Ramanujam, R., Zhao, Y., Pirskanen, R., Hammarström, L.(2010). Lack of association of the CIITA -168A→G promoter SNP with myasthenia gravis and its role in autoimmunity . BMC Medical Genetics. 11. (1).
Sakthivel, P., Giscombe, R., Ramanujam, R., Lefvert, A.K.(2009). Polymorphisms in PDCD1 gene are not associated with Wegener's granulomatosis . Rheumatology International. 29. (10). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1247-1250.
Sakthivel, P, Giscombe, R, Ramanujam, R, Lefvert, AK (2009). Polymorphisms in PDCD1 gene are not associated with Wegener's granulomatosis . Rheumatol. Int.
Sakthivel, P., Ramanujam, R., Wang, X.B., Pirskanen, R., Lefvert, A.K.(2008). Programmed Death-1: From gene to protein in autoimmune human myasthenia gravis . Journal of Neuroimmunology. 193. (1-2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 149-155.
Sakthivel, P, RamanujaM, R, Wang, XB, Pirskanen, R, Lefvert, AK (2008). Programmed Death-1: From gene to protein in autoimmune human myasthenia gravis . J. Neuroimmunol.
Lefvert, A.K., Zhao, Y., Ramanujam, R., Yu, S., Pirskanen, R., Hammarström, L.(2008). PTPN22 R620W promotes production of anti-AChR autoantibodies and IL-2 in myasthenia gravis . Journal of Neuroimmunology. 197. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 110-113.
Lefvert, AK, Zhao, YF, Ramanujam, R, Yu, SY, Pirskanen, R, Hammarstrom, L (2008). PTPN22 R620W promotes production of anti-AChR autoantibodies and IL-2 in myasthenia gravis . J. Neuroimmunol.
Brungart, T.A., Lauchle, G.C., Ramanujam, R.K.(1999). Installation effects on fan acoustic and aerodynamic performance . Noise Control Engineering Journal. 47. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 3-7.
Brungart, TA, Lauchle, GC, Ramanujam, RK (1999). Installation effects on fan acoustic and aerodynamic performance. Noise Control Eng. J.